Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309293695> ?p ?o ?g. }
- W4309293695 abstract "BackgroundAdjuvant aromatase inhibitors increase osteoporosis and fractures in patients with hormone receptor–positive breast cancer. We have previously reported outcomes of the ABCSG-18 (study 18 from the Austrian Breast & Colorectal Cancer Study Group) trial showing that adjuvant anti–receptor activator of nuclear factor-κB ligand denosumab treatment counteracts these adverse effects and may improve outcomes. We report here the final long-term outcomes.MethodsABCSG-18 is a prospective, double-blind, placebo-controlled, phase 3 trial in which 3425 postmenopausal patients with early hormone receptor–positive breast cancer receiving aromatase inhibitor therapy were randomly assigned in 58 trial centers to receive either denosumab 60 mg or placebo administered subcutaneously every 6 months. The primary end point was the time to first clinical fracture after randomization. Secondary disease outcome–related end points were disease-free survival (DFS), bone metastasis–free survival (BMFS), and overall survival (OS).ResultsFor this final protocol-defined analysis, median follow-up is 8 years (interquartile range, 6 to 9.6 years). There were 309 versus 368 DFS events (hazard ratio, 0.83; 95% confidence interval [CI], 0.71 to 0.97) in the denosumab versus the placebo group, respectively, resulting in an absolute 9-year DFS benefit of 3.5 percentage points (79.4 vs. 75.9%). Adjuvant denosumab improved BMFS by 2.5 percentage points (88.9 vs. 86.4%; hazard ratio, 0.81; 95% CI, 0.65 to 1.00) and OS by 1.0 percentage point (90.9 vs. 89.9%; hazard ratio, 0.80; 95% CI, 0.64 to 1.01). No new toxicities for this dose of adjuvant denosumab were observed.ConclusionsDFS, BMFS, and OS continued to show benefit in this final long-term analysis of ABCSG-18. There were no new toxicities. (Funded by Amgen; ClinicalTrials.gov number, NCT00556374.)" @default.
- W4309293695 created "2022-11-25" @default.
- W4309293695 creator A5013406094 @default.
- W4309293695 creator A5015052494 @default.
- W4309293695 creator A5018732880 @default.
- W4309293695 creator A5019454470 @default.
- W4309293695 creator A5022097827 @default.
- W4309293695 creator A5036026407 @default.
- W4309293695 creator A5036695602 @default.
- W4309293695 creator A5038898280 @default.
- W4309293695 creator A5038918684 @default.
- W4309293695 creator A5039097727 @default.
- W4309293695 creator A5039994927 @default.
- W4309293695 creator A5040658545 @default.
- W4309293695 creator A5042756447 @default.
- W4309293695 creator A5045803325 @default.
- W4309293695 creator A5045884626 @default.
- W4309293695 creator A5052533257 @default.
- W4309293695 creator A5062996283 @default.
- W4309293695 creator A5068091207 @default.
- W4309293695 creator A5071242403 @default.
- W4309293695 creator A5073168272 @default.
- W4309293695 creator A5075260634 @default.
- W4309293695 creator A5078571816 @default.
- W4309293695 creator A5080544752 @default.
- W4309293695 creator A5082631402 @default.
- W4309293695 creator A5084303748 @default.
- W4309293695 creator A5086400759 @default.
- W4309293695 creator A5086817452 @default.
- W4309293695 date "2022-11-22" @default.
- W4309293695 modified "2023-10-03" @default.
- W4309293695 title "Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer" @default.
- W4309293695 cites W2009232905 @default.
- W4309293695 cites W2096360340 @default.
- W4309293695 cites W2115335453 @default.
- W4309293695 cites W2122786185 @default.
- W4309293695 cites W2137830201 @default.
- W4309293695 cites W2138691465 @default.
- W4309293695 cites W2148096512 @default.
- W4309293695 cites W2148226416 @default.
- W4309293695 cites W2158885364 @default.
- W4309293695 cites W2160005424 @default.
- W4309293695 cites W2171595133 @default.
- W4309293695 cites W2214665719 @default.
- W4309293695 cites W2314428698 @default.
- W4309293695 cites W2539991828 @default.
- W4309293695 cites W2618970366 @default.
- W4309293695 cites W2619448414 @default.
- W4309293695 cites W2791535250 @default.
- W4309293695 cites W2893634531 @default.
- W4309293695 cites W2915626967 @default.
- W4309293695 cites W2990876124 @default.
- W4309293695 cites W3015777386 @default.
- W4309293695 cites W3162326693 @default.
- W4309293695 cites W3176176740 @default.
- W4309293695 cites W3179495039 @default.
- W4309293695 cites W3182336945 @default.
- W4309293695 cites W3183205402 @default.
- W4309293695 cites W3206192000 @default.
- W4309293695 cites W4210331534 @default.
- W4309293695 cites W4211032970 @default.
- W4309293695 cites W4226348827 @default.
- W4309293695 doi "https://doi.org/10.1056/evidoa2200162" @default.
- W4309293695 hasPublicationYear "2022" @default.
- W4309293695 type Work @default.
- W4309293695 citedByCount "6" @default.
- W4309293695 countsByYear W43092936952022 @default.
- W4309293695 countsByYear W43092936952023 @default.
- W4309293695 crossrefType "journal-article" @default.
- W4309293695 hasAuthorship W4309293695A5013406094 @default.
- W4309293695 hasAuthorship W4309293695A5015052494 @default.
- W4309293695 hasAuthorship W4309293695A5018732880 @default.
- W4309293695 hasAuthorship W4309293695A5019454470 @default.
- W4309293695 hasAuthorship W4309293695A5022097827 @default.
- W4309293695 hasAuthorship W4309293695A5036026407 @default.
- W4309293695 hasAuthorship W4309293695A5036695602 @default.
- W4309293695 hasAuthorship W4309293695A5038898280 @default.
- W4309293695 hasAuthorship W4309293695A5038918684 @default.
- W4309293695 hasAuthorship W4309293695A5039097727 @default.
- W4309293695 hasAuthorship W4309293695A5039994927 @default.
- W4309293695 hasAuthorship W4309293695A5040658545 @default.
- W4309293695 hasAuthorship W4309293695A5042756447 @default.
- W4309293695 hasAuthorship W4309293695A5045803325 @default.
- W4309293695 hasAuthorship W4309293695A5045884626 @default.
- W4309293695 hasAuthorship W4309293695A5052533257 @default.
- W4309293695 hasAuthorship W4309293695A5062996283 @default.
- W4309293695 hasAuthorship W4309293695A5068091207 @default.
- W4309293695 hasAuthorship W4309293695A5071242403 @default.
- W4309293695 hasAuthorship W4309293695A5073168272 @default.
- W4309293695 hasAuthorship W4309293695A5075260634 @default.
- W4309293695 hasAuthorship W4309293695A5078571816 @default.
- W4309293695 hasAuthorship W4309293695A5080544752 @default.
- W4309293695 hasAuthorship W4309293695A5082631402 @default.
- W4309293695 hasAuthorship W4309293695A5084303748 @default.
- W4309293695 hasAuthorship W4309293695A5086400759 @default.
- W4309293695 hasAuthorship W4309293695A5086817452 @default.
- W4309293695 hasConcept C119060515 @default.
- W4309293695 hasConcept C121608353 @default.
- W4309293695 hasConcept C126322002 @default.
- W4309293695 hasConcept C143998085 @default.